作者: Lia C. Upegui-Gonzalez , Huynh T. Duc , Yves Buisson , Michel Arborio , Christiane Lafarge-Frayssinet
DOI: 10.1007/978-1-4615-5357-1_6
关键词:
摘要: Hepatocellular carcinoma (HCC) is one of the most common human malignant tumours, it causes more than 1 million deaths per year in world [20], a multi factorial disease linked to etiology factors as chemical carcinogens and virus. Chemotherapy radiotherapy are relatively ineffective even after modern innovations. Surgery only treatment at moment but not always applicable, accounts for remission 15–20% cases. The prognosis HCC patients depends on this possibility resection [3,6,19].